Isavuconazonium Sulfate Injection and Piqray
Determining the interaction of Isavuconazonium Sulfate Injection and Piqray and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: Coadministration of inhibitors of the breast cancer resistance protein (BCRP) transporter with alpelisib may increase the plasma concentrations and risk of adverse effects of alpelisib, which is a substrate of this efflux transporter. Alpelisib has been identified as a substrate of BCRP in in vitro studies. However, clinical data are not available. MANAGEMENT: According to the manufacturer, concomitant use of alpelisib with BCRP inhibitors should be avoided. If coadministration is required, patients should be closely monitored for alpelisib-related adverse reactions, including hyperglycemia, diarrhea, rash, acute kidney injury, abdominal pain, and anemia. References "Product Information. Piqray (alpelisib)." Novartis Pharmaceuticals, East Hanover, NJ.
Professional:GENERALLY AVOID: Coadministration of inhibitors of the breast cancer resistance protein (BCRP) transporter with alpelisib may increase the plasma concentrations and risk of adverse effects of alpelisib, which is a substrate of this efflux transporter. Alpelisib has been identified as a substrate of BCRP in in vitro studies. However, clinical data are not available.
MANAGEMENT: According to the manufacturer, concomitant use of alpelisib with BCRP inhibitors should be avoided. If coadministration is required, patients should be closely monitored for alpelisib-related adverse reactions, including hyperglycemia, diarrhea, rash, acute kidney injury, abdominal pain, and anemia.
- "Product Information. Piqray (alpelisib)." Novartis Pharmaceuticals, East Hanover, NJ.
Generic Name: isavuconazonium
Brand name: Cresemba
Synonyms: Isavuconazonium, Isavuconazonium Sulfate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Isavuconazonium Sulfate Injection-Piqray 200MG Daily Dose
- Isavuconazonium Sulfate Injection-Piqray 250MG Daily Dose
- Isavuconazonium Sulfate Injection-Piqray 300MG Daily Dose
- Isavuconazonium Sulfate Injection-Pirbuterol Inhalation
- Isavuconazonium Sulfate Injection-Pirfenidone
- Isavuconazonium Sulfate Injection-Pirmella 1/35
- Piqray-Isentress
- Piqray-Isentress (Raltegravir Chewable Tablets)
- Piqray-Isentress (Raltegravir Powder for Oral Suspension)
- Piqray-Isentress (Raltegravir Tablets)
- Piqray-Isentress HD
- Piqray-Isibloom